REPORTS

Let’s Pullulate and Expand Your Business

Receptor Tyrosine Protein Kinase ERBB 4 Market - Global Professional Analysis and Forecast to 2026

Jan 10, 2020  |  217 PAGES  |  REPORT CODE: CMM260772
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Receptor Tyrosine Protein Kinase ERBB 4 market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.7% during the forecast period.

This report presents the market size and development trends by detailing the Receptor Tyrosine Protein Kinase ERBB 4 market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Receptor Tyrosine Protein Kinase ERBB 4 market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Receptor Tyrosine Protein Kinase ERBB 4 industry and will help you to build a panoramic view of the industrial development.

Receptor Tyrosine Protein Kinase ERBB 4 Market, By Type:

  • PB-357

  • NT-113

  • NRG-4

  • MIN-301

  • Others

Receptor Tyrosine Protein Kinase ERBB 4 Market, By Application:

  • Skin Cancer

  • Systolic Heart Failure

  • Neuroblastoma

  • Oligodendroglioma

  • Others

Some of the leading players are as follows:

  • Aslan Pharmaceuticals Pte Ltd

  • Boehringer Ingelheim GmbH

  • Minerva Neurosciences Inc

  • Jiangsu Kanion Pharmaceutical Co Ltd

  • Pfizer Inc

  • Zensun (Shanghai) Sci & Tech Co Ltd

  • Hanmi Pharmaceuticals Co Ltd

  • GamaMabs Pharma SA

  • XuanZhu Pharma Co Ltd

  • Puma Biotechnology Inc

  • Shanghai Fosun Pharmaceutical (Group) Co Ltd

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Receptor Tyrosine Protein Kinase ERBB 4 Market: Technology Type Analysis

  • 4.1 Receptor Tyrosine Protein Kinase ERBB 4 Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Receptor Tyrosine Protein Kinase ERBB 4 Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 PB-357

    • 4.3.2 NT-113

    • 4.3.3 NRG-4

    • 4.3.4 MIN-301

    • 4.3.5 Others

5 Receptor Tyrosine Protein Kinase ERBB 4 Market: Product Analysis

  • 5.1 Receptor Tyrosine Protein Kinase ERBB 4 Product Market Share Analysis, 2018 & 2026

  • 5.2 Receptor Tyrosine Protein Kinase ERBB 4 Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Receptor Tyrosine Protein Kinase ERBB 4 Market: Application Analysis

  • 6.1 Receptor Tyrosine Protein Kinase ERBB 4 Application Market Share Analysis, 2018 & 2026

  • 6.2 Receptor Tyrosine Protein Kinase ERBB 4 Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Skin Cancer

    • 6.3.2 Systolic Heart Failure

    • 6.3.3 Neuroblastoma

    • 6.3.4 Oligodendroglioma

    • 6.3.5 Others

7 Receptor Tyrosine Protein Kinase ERBB 4 Market: Regional Analysis

  • 7.1 Receptor Tyrosine Protein Kinase ERBB 4 Regional Market Share Analysis, 2018 & 2026

  • 7.2 Receptor Tyrosine Protein Kinase ERBB 4 Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Aslan Pharmaceuticals Pte Ltd

    • 9.1.1 Aslan Pharmaceuticals Pte Ltd Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Boehringer Ingelheim GmbH

    • 9.2.1 Boehringer Ingelheim GmbH Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Minerva Neurosciences Inc

    • 9.3.1 Minerva Neurosciences Inc Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Jiangsu Kanion Pharmaceutical Co Ltd

    • 9.4.1 Jiangsu Kanion Pharmaceutical Co Ltd Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Pfizer Inc

    • 9.5.1 Pfizer Inc Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Zensun (Shanghai) Sci & Tech Co Ltd

    • 9.6.1 Zensun (Shanghai) Sci & Tech Co Ltd Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Hanmi Pharmaceuticals Co Ltd

    • 9.7.1 Hanmi Pharmaceuticals Co Ltd Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 GamaMabs Pharma SA

    • 9.8.1 GamaMabs Pharma SA Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 XuanZhu Pharma Co Ltd

    • 9.9.1 XuanZhu Pharma Co Ltd Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Puma Biotechnology Inc

    • 9.10.1 Puma Biotechnology Inc Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Shanghai Fosun Pharmaceutical (Group) Co Ltd

    • 9.11.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

 

The List of Tables and Figures (Totals 105 Figures and 143 Tables)

  • Figure PB-357 Receptor Tyrosine Protein Kinase ERBB 4 market, 2015 - 2026 (USD Million)

  • Figure NT-113 Receptor Tyrosine Protein Kinase ERBB 4 market, 2015 - 2026 (USD Million)

  • Figure NRG-4 Receptor Tyrosine Protein Kinase ERBB 4 market, 2015 - 2026 (USD Million)

  • Figure MIN-301 Receptor Tyrosine Protein Kinase ERBB 4 market, 2015 - 2026 (USD Million)

  • Figure Others Receptor Tyrosine Protein Kinase ERBB 4 market, 2015 - 2026 (USD Million)

  • Figure Skin Cancer market, 2015 - 2026 (USD Million)

  • Figure Systolic Heart Failure market, 2015 - 2026 (USD Million)

  • Figure Neuroblastoma market, 2015 - 2026 (USD Million)

  • Figure Oligodendroglioma market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Receptor Tyrosine Protein Kinase ERBB 4 market, by country, 2015 - 2026 (USD Million)

  • Table North America Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table North America Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table North America Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table Canada Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table Canada Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Europe Receptor Tyrosine Protein Kinase ERBB 4 market, by country, 2015 - 2026 (USD Million)

  • Table Europe Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table Europe Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table Europe Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table Germany Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table Germany Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table France Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table France Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table Italy Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table Italy Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table Spain Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table Spain Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table China Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table China Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table Japan Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table Japan Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table India Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table India Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Receptor Tyrosine Protein Kinase ERBB 4 market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table MEA Receptor Tyrosine Protein Kinase ERBB 4 market, by country, 2015 - 2026 (USD Million)

  • Table MEA Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table MEA Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table MEA Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Receptor Tyrosine Protein Kinase ERBB 4 market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Receptor Tyrosine Protein Kinase ERBB 4 market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Receptor Tyrosine Protein Kinase ERBB 4 market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Aslan Pharmaceuticals Pte Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Boehringer Ingelheim GmbH Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Minerva Neurosciences Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Jiangsu Kanion Pharmaceutical Co Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Zensun (Shanghai) Sci & Tech Co Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hanmi Pharmaceuticals Co Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GamaMabs Pharma SA Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table XuanZhu Pharma Co Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Puma Biotechnology Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Shanghai Fosun Pharmaceutical (Group) Co Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top